AnaptysBio, Inc. (ANAB)
66.83
-0.53
(-0.79%)
USD |
NASDAQ |
May 07, 16:00
66.83
0.00 (0.00%)
After-Hours: 20:00
AnaptysBio Research and Development Expense (Annual) : 135.41M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Vanda Pharmaceuticals, Inc. | 109.27M |
| ADMA Biologics, Inc. | 4.762M |
| Nektar Therapeutics | 117.07M |
| Rigel Pharmaceuticals, Inc. | 33.30M |
| Axsome Therapeutics, Inc. | 182.78M |